Some SNPs in NER pathway genes correlated with toxicity in advanced non-small-cell lung cancer patients treated with chemotherapy, especially for SNPs of MMS19L, RRM1 and ERCC5, may have some effect to predict the adverse events of chemotherapy in NSCLC patients. The gene discussed is RRM1; the disease is non-small cell lung carcinoma.